Computational modeling of cyclic peptide inhibitor–MDM2/MDMX binding through global docking and Gaussian accelerated molecular dynamics simulations

References

• Berberich, S. J. (2014). Mdm2 and MdmX involvement in human cancer. In S. P. Deb & S. Deb (Eds.), Mutant p53 and MDM2 in cancer (pp. 263–280). Springer.
   Google Scholar
• Bernal, F., Wade, M., Godes, M., Davis, T. N., Whitehead, D. G., Kung, A. L., Wahl, G. M., & Walensky, L. D. (2010). A stapled p53 helix overcomes HDMX-mediated suppression of p53. Cancer Cell, 18(5), 411–422. doi:10.1016/j.ccr.2010.10.024
   PubMed Web of Science ®Google Scholar
• Bhat, S., & Purisima, E. O. (2006). Molecular surface generation using a variable-radius solvent probe. Proteins, 62(1), 244–261. doi:10.1002/prot.20682
   PubMed Web of Science ®Google Scholar
• Cheok, C. F., Verma, C. S., Baselga, J., & Lane, D. P. (2011). Translating p53 into the clinic. Nature Reviews. Clinical Oncology, 8(1), 25–37. http://www.nature.com/nrclinonc/journal/v8/n1/suppinfo/nrclinonc.2010.174_S1.html doi:10.1038/nrclinonc.2010.174
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N [center-dot] log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. doi:10.1063/1.464397
   Web of Science ®Google Scholar
• Duffy, M. J., Synnott, N. C., McGowan, P. M., Crown, J., O'Connor, D., & Gallagher, W. M. (2014). p53 as a target for the treatment of cancer. Cancer Treatment Reviews, 40(10), 1153–1160. doi:10.1016/j.ctrv.2014.10.004
   PubMed Web of Science ®Google Scholar
• Fry, D. C., Graves, B., & Vassilev, L. T. (2005). Development of E3‐Substrate (MDM2‐p53)–binding inhibitors: Structural aspects. In J. D. Raymond (Ed.), Methods in enzymology (Vol. 399, pp. 622–633). Academic Press.
   Google Scholar
• Götz, A. W., Williamson, M. J., Xu, D., Poole, D., Le Grand, S., & Walker, R. C. (2012). Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born. Journal of Chemical Theory and Computation, 8(5), 1542–1555. doi:10.1021/ct200909j
   PubMed Web of Science ®Google Scholar
• Garabedian, A., Bolufer, A., Leng, F., & Fernandez-Lima, F. (2018). Peptide Sequence influence on the conformational dynamics and DNA binding of the intrinsically disordered AT-Hook 3 peptide. Scientific Reports, 8(1), 10783. doi:10.1038/s41598-018-28956-z
   PubMed Web of Science ®Google Scholar
• Gasper, P. M., Fuglestad, B., Komives, E. A., Markwick, P. R. L., & McCammon, J. A. (2012). Allosteric networks in thrombin distinguish procoagulant vs. anticoagulant activities. Proceedings of the National Academy of Sciences of the United States of America, 109(52), 21216–21222. doi:10.1073/pnas.1218414109
   PubMed Web of Science ®Google Scholar
• Goldbach, L., Vermeulen, B. J. A., Caner, S., Liu, M., Tysoe, C., van Gijzel, L., Yoshisada, R., Trellet, M., van Ingen, H., Brayer, G. D., Bonvin, A. M. J. J., & Jongkees, S. A. K. (2019). Folding then binding vs folding through binding in macrocyclic peptide inhibitors of human pancreatic α-amylase. ACS Chemical Biology, 14(8), 1751–1759. doi:10.1021/acschembio.9b00290
   PubMed Web of Science ®Google Scholar
• Honda, R., Tanaka, H., & Yasuda, H. (1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Letters, 420(1), 25–27. doi:10.1016/S0014-5793(97)01480-4
   PubMed Web of Science ®Google Scholar
• Isobe, M., Emanuel, B. S., Givol, D., Oren, M., & Croce, C. M. (1986). Localization of gene for human p53 tumour antigen to band 17p13. Nature, 320(6057), 84–85. doi:10.1038/320084a0
   PubMed Web of Science ®Google Scholar
• Iwazaki, T., Li, X., & Harada, K. (2005). Evolvability of the mode of peptide binding by an RNA. RNA (New York, N.Y.), 11(9), 1364–1373. doi:10.1261/rna.2560905
   PubMed Web of Science ®Google Scholar
• Kozakov, D., Brenke, R., Comeau, S. R., & Vajda, S. (2006). PIPER: An FFT-based protein docking program with pairwise potentials. Proteins, 65(2), 392–406. doi:10.1002/prot.21117
   PubMed Web of Science ®Google Scholar
• Kozakov, D., Hall, D. R., Xia, B., Porter, K. A., Padhorny, D., Yueh, C., Beglov, D., & Vajda, S. (2017). The ClusPro web server for protein–protein docking. Nature Protocols, 12(2), 255–278. doi:10.1038/nprot.2016.169
   PubMed Web of Science ®Google Scholar
• Kurcinski, M., Jamroz, M., Blaszczyk, M., Kolinski, A., & Kmiecik, S. (2015). CABS-dock web server for the flexible docking of peptides to proteins without prior knowledge of the binding site. Nucleic Acids Research, 43(W1), W419–W424. doi:10.1093/nar/gkv456
   PubMed Web of Science ®Google Scholar
• Le Grand, S., Götz, A. W., & Walker, R. C. (2013). SPFP: Speed without compromise—A mixed precision model for GPU accelerated molecular dynamics simulations. Computer Physics Communications, 184(2), 374–380. doi:10.1016/j.cpc.2012.09.022
   Web of Science ®Google Scholar
• Lee, H., Heo, L., Lee, M. S., & Seok, C. (2015). GalaxyPepDock: A protein-peptide docking tool based on interaction similarity and energy optimization. Nucleic Acids Research, 43(W1), W431–W435. doi:10.1093/nar/gkv495
   PubMed Web of Science ®Google Scholar
• Li, C., Pazgier, M., Li, C., Yuan, W., Liu, M., Wei, G., Lu, W.-Y., & Lu, W. (2010). Systematic mutational analysis of peptide inhibition of the p53-MDM2/MDMX interactions. Journal of Molecular Biology, 398(2), 200–213. doi:10.1016/j.jmb.2010.03.005
   PubMed Web of Science ®Google Scholar
• Lill, M. A., & Thompson, J. J. (2011). Solvent interaction energy calculations on molecular dynamics trajectories: Increasing the efficiency using systematic frame selection. Journal of Chemical Information and Modeling, 51(10), 2680–2689. doi:10.1021/ci200191m
   PubMed Web of Science ®Google Scholar
• London, N., Raveh, B., Cohen, E., Fathi, G., & Schueler-Furman, O. (2011). Rosetta FlexPepDock web server-high resolution modeling of peptide-protein interactions. Nucleic Acids Research, 39(Web Server issue), W249–W253. doi:10.1093/nar/gkr431
   PubMed Web of Science ®Google Scholar
• Macchiarulo, A., Giacche, N., Carotti, A., Moretti, F., & Pellicciari, R. (2011). Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4). MedChemComm, 2(6), 455–465. doi:10.1039/c0md00238k
   Web of Science ®Google Scholar
• Marine, J.-C. (2011). Chapter 3 - MDM2 and MDMX in cancer and development. In A. D. Michael (Ed.), Current topics in developmental biology (Vol. 94, pp. 45–75). Academic Press.
   Google Scholar
• Marine, J.-C W., Dyer, M. A., & Jochemsen, A. G. (2007). MDMX: From bench to bedside. Journal of Cell Science, 120(Pt 3), 371–378. doi:10.1242/jcs.03362
   PubMed Web of Science ®Google Scholar
• Markwick, P. R. L., Pierce, L. C. T., Goodin, D. B., & McCammon, J. A. (2011). Adaptive Accelerated Molecular Dynamics (Ad-AMD) revealing the molecular plasticity of P450cam. The Journal of Physical Chemistry Letters, 2(3), 158–164. doi:10.1021/jz101462n
   PubMed Web of Science ®Google Scholar
• McBride, O. W., Merry, D., & Givol, D. (1986). The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13). Proceedings of the National Academy of Sciences of the United States of America, 83(1), 130–134. doi:10.1073/pnas.83.1.130
   PubMed Web of Science ®Google Scholar
• Miao, Y., Feher, V. A., & McCammon, J. A. (2015). Gaussian accelerated molecular dynamics: Unconstrained enhanced sampling and free energy calculation. Journal of Chemical Theory and Computation, 11(8), 3584–3595. doi:10.1021/acs.jctc.5b00436
   PubMed Web of Science ®Google Scholar
• Miao, Y., Sinko, W., Pierce, L., Bucher, D., Walker, R. C., & McCammon, J. A. (2014). Improved reweighting of accelerated molecular dynamics simulations for free energy calculation. Journal of Chemical Theory and Computation, 10(7), 2677–2689. doi:10.1021/ct500090q
   PubMed Web of Science ®Google Scholar
• Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992). The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69(7), 1237–1245. doi:10.1016/0092-8674(92)90644-R
   PubMed Web of Science ®Google Scholar
• Naïm, M., Bhat, S., Rankin, K. N., Dennis, S., Chowdhury, S. F., Siddiqi, I., Drabik, P., Sulea, T., Bayly, C. I., Jakalian, A., & Purisima, E. O. (2007). Solvated Interaction Energy (SIE) for scoring protein-ligand binding affinities. 1. Exploring the parameter space. Journal of Chemical Information and Modeling, 47(1), 122–133. doi:10.1021/ci600406v
   PubMed Web of Science ®Google Scholar
• Noguchi, T., Oishi, S., Honda, K., Kondoh, Y., Saito, T., Kubo, T., Kaneda, M., Ohno, H., Osada, H., & Fujii, N. (2013). Affinity-based screening of MDM2/MDMX-p53 interaction inhibitors by chemical array: Identification of novel peptidic inhibitors. Bioorganic & Medicinal Chemistry Letters, 23(13), 3802–3805. doi:10.1016/j.bmcl.2013.04.094
   PubMed Web of Science ®Google Scholar
• Obarska-Kosinska, A., Iacoangeli, A., Lepore, R., & Tramontano, A. (2016). PepComposer: Computational design of peptides binding to a given protein surface. Nucleic Acids Research, 44(W1), W522–W528. doi:10.1093/nar/gkw366
   PubMed Web of Science ®Google Scholar
• Otto, M., Süßmuth, R., Vuong, C., Jung, G., & Götz, F. (1999). Inhibition of virulence factor expression in Staphylococcus aureus by the Staphylococcus epidermidis agr pheromone and derivatives. FEBS Letters, 450(3), 257–262. doi:10.1016/S0014-5793(99)00514-1
   PubMed Web of Science ®Google Scholar
• Pazgier, M., Liu, M., Zou, G., Yuan, W., Li, C., Li, C., Li, J., Monbo, J., Zella, D., Tarasov, S. G., & Lu, W. (2009). Structural basis for high-affinity peptide inhibition of p53 interactions with MDM2 and MDMX. Proceedings of the National Academy of Sciences of the United States of America, 106(12), 4665–4670. doi:10.1073/pnas.0900947106
   PubMed Web of Science ®Google Scholar
• Perdih, A., Bren, U., & Solmajer, T. (2009). Binding free energy calculations of N-sulphonyl-glutamic acid inhibitors of MurD ligase. Journal of Molecular Modeling, 15(8), 983–996. doi:10.1007/s00894-009-0455-8
   PubMed Web of Science ®Google Scholar
• Petsalaki, E., & Russell, R. B. (2008). Peptide-mediated interactions in biological systems: New discoveries and applications. Current Opinion in Biotechnology, 19(4), 344–350. doi:10.1016/j.copbio.2008.06.004
   PubMed Web of Science ®Google Scholar
• Pierce, L. C. T., Salomon-Ferrer, R., Augusto F. de Oliveira, C., McCammon, J. A., & Walker, R. C. (2012). Routine access to millisecond time scale events with accelerated molecular dynamics. Journal of Chemical Theory and Computation, 8(9), 2997–3002. doi:10.1021/ct300284c
   PubMed Web of Science ®Google Scholar
• Porter, K. A., Xia, B., Beglov, D., Bohnuud, T., Alam, N., Schueler-Furman, O., & Kozakov, D. (2017). ClusPro PeptiDock: Efficient global docking of peptide recognition motifs using FFT. Bioinformatics (Oxford, England), 33(20), 3299–3301. doi:10.1093/bioinformatics/btx216
   PubMed Web of Science ®Google Scholar
• Purisima, E. O. (1998). Fast summation boundary element method for calculating solvation free energies of macromolecules. Journal of Computational Chemistry, 19(13), 1494–1504. doi:10.1002/(SICI)1096-987X(199810)19:13 < 1494::AID-JCC6 > 3.0.CO;2-L
   Web of Science ®Google Scholar
• Purisima, E. O., & Nilar, S. H. (1995). A simple yet accurate boundary element method for continuum dielectric calculations. Journal of Computational Chemistry, 16(6), 681–689. doi:10.1002/jcc.540160604
   Web of Science ®Google Scholar
• Roe, D. R., & Cheatham, T. E. (2013). PTRAJ and CPPTRAJ: Software for processing and analysis of molecular dynamics trajectory data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. doi:10.1021/ct400341p
   PubMed Web of Science ®Google Scholar
• Ryckaert, J.-P., Ciccotti, G., & Berendsen, H. J. C. (1977). Numerical integration of the Cartesian equations of motion of a system with constraints: Molecular dynamics of n-alkanes. Journal of Computational Physics, 23(3), 327–341. doi:10.1016/0021-9991(77)90098-5
   Web of Science ®Google Scholar
• Salomon-Ferrer, R., Götz, A. W., Poole, D., Le Grand, S., & Walker, R. C. (2013). Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle Mesh Ewald. Journal of Chemical Theory and Computation, 9(9), 3878–3888. doi:10.1021/ct400314y
   PubMed Web of Science ®Google Scholar
• Shangary, S., & Wang, S. (2009). Small-molecule inhibitors of the MDM2-p53 protein-protein interaction to reactivate p53 function: A novel approach for cancer therapy. Annual Review of Pharmacology and Toxicology, 49(1), 223–241. doi:10.1146/annurev.pharmtox.48.113006.094723
   PubMed Web of Science ®Google Scholar
• Toledo, F., & Wahl, G. M. (2007). MDM2 and MDM4: p53 regulators as targets in anticancer therapy. The International Journal of Biochemistry & Cell Biology, 39(7–8), 1476–1482. doi:10.1016/j.biocel.2007.03.022
   PubMed Web of Science ®Google Scholar
• Vajda, S., Yueh, C., Beglov, D., Bohnuud, T., Mottarella, S. E., Xia, B., Hall, D. R., & Kozakov, D. (2017). New additions to the ClusPro server motivated by CAPRI. Proteins, 85(3), 435–444. doi:10.1002/prot.25219
   PubMed Web of Science ®Google Scholar
• Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., Fotouhi, N., & Liu, E. A. (2004). In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science (New York, N.Y.), 303(5659), 844–848. doi:10.1126/science.1092472
   PubMed Web of Science ®Google Scholar
• Vogelstein, B., Lane, D., & Levine, A. J. (2000). Surfing the p53 network. Nature, 408(6810), 307–310. doi:10.1038/35042675
   PubMed Web of Science ®Google Scholar
• Wade, M., & Wahl, G. M. (2009). Targeting Mdm2 and Mdmx in cancer therapy: Better living through medicinal chemistry? Molecular Cancer Research: MCR, 7(1), 1–11. doi:10.1158/1541-7786.mcr-08-0423
   PubMed Web of Science ®Google Scholar
• Wang, J., Alekseenko, A., Kozakov, D., & Miao, Y. (2019). Improved modeling of peptide-protein binding through global docking and accelerated molecular dynamics simulations. Frontiers in Molecular Biosciences, 6(112), 112. doi:10.3389/fmolb.2019.00112
   PubMed Web of Science ®Google Scholar
• Wang, Y.-T., & Su, Z.-Y. (2011). Modelling and predicting the binding mechanics of HIV P1053-0.5β antibody complex. Molecular Simulation, 37(2), 164–171. doi:10.1080/08927022.2010.533274
   Web of Science ®Google Scholar
• Wang, Y., Markwick, P. R. L., de Oliveira, C. A. F., & McCammon, J. A. (2011). Enhanced lipid diffusion and mixing in accelerated molecular dynamics. Journal of Chemical Theory and Computation, 7(10), 3199–3207. doi:10.1021/ct200430c
   PubMed Web of Science ®Google Scholar
• Wendler, K., Thar, J., Zahn, S., & Kirchner, B. (2010). Estimating the hydrogen bond energy. The Journal of Physical Chemistry. A, 114(35), 9529–9536. doi:10.1021/jp103470e
   PubMed Web of Science ®Google Scholar
• Yang, C., Zhang, S., Bai, Z., Hou, S., Wu, D., Huang, J., & Zhou, P. (2016). A two-step binding mechanism for the self-binding peptide recognition of target domains. Molecular Biosystems, 12(4), 1201–1213. doi:10.1039/C5MB00800J
   PubMedGoogle Scholar
• Zhang, Y., & Sanner, M. F. (2019). AutoDock CrankPep: Combining folding and docking to predict protein-peptide complexes. Bioinformatics (Oxford, England), 35(24), 5121–5127. doi:10.1093/bioinformatics/btz459
   PubMed Web of Science ®Google Scholar